An Inflammation-Related Nine-Gene Signature to Improve Prognosis Prediction of Lung Adenocarcinoma

Table 3

Clinical characteristics of patients with LUAD in different risk groups.

Parameters	Group	Total; (500)	High risk; (250)	Low risk; (250)	value
Gender	Male	230	125	105	0.073
	Female	270	125	145
Age (years)	<65	219	127	92	0.002
	≥65	281	123	158
Clinical stage	I-II	387	183	204	0.023
	III-IV	113	67	46